Physical Activity Level and Sleep Quality in Type 2 Diabetes
NCT ID: NCT06602778
Last Updated: 2025-03-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
80 participants
OBSERVATIONAL
2024-09-20
2025-02-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Exercise and Metformin on Methylglyoxal Levels in Prediabetic Individuals
NCT06603480
Effect of Exercise on MiR-126 in Individuals With Prediabetes
NCT06809257
The Effect of Exercises Performed According to Circadian Rhythm in Type 2 Diabetes
NCT04427488
The Effects of Upper Extremity Aerobic Exercise Training in Patients With Type 2 Diabetes
NCT06132334
The Effects of Calisthenic Exercise Training in Patients With Type 2 Diabetes
NCT06222086
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T2DM-BMI0
Biomarkers / blood
Analysis of routine biochemical parameters
Questionnaire
Physical activity level will be assessed using the International Physical Activity Questionnaire Short Form (IPQI) and sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The data to be obtained from blood will be obtained by selecting blood samples that will be sent to biological waste.
T2DM-BMI1
Biomarkers / blood
Analysis of routine biochemical parameters
Questionnaire
Physical activity level will be assessed using the International Physical Activity Questionnaire Short Form (IPQI) and sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The data to be obtained from blood will be obtained by selecting blood samples that will be sent to biological waste.
T2DM-BMI2
Biomarkers / blood
Analysis of routine biochemical parameters
Questionnaire
Physical activity level will be assessed using the International Physical Activity Questionnaire Short Form (IPQI) and sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The data to be obtained from blood will be obtained by selecting blood samples that will be sent to biological waste.
T2DM-BMI3
Biomarkers / blood
Analysis of routine biochemical parameters
Questionnaire
Physical activity level will be assessed using the International Physical Activity Questionnaire Short Form (IPQI) and sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The data to be obtained from blood will be obtained by selecting blood samples that will be sent to biological waste.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biomarkers / blood
Analysis of routine biochemical parameters
Questionnaire
Physical activity level will be assessed using the International Physical Activity Questionnaire Short Form (IPQI) and sleep quality will be assessed using the Pittsburgh Sleep Quality Index (PSQI). The data to be obtained from blood will be obtained by selecting blood samples that will be sent to biological waste.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Volunteering to participate in the study
* Being literate
* Being diagnosed with Type 2 Diabetes
Exclusion Criteria
* malignant disease,
* infectious disease,
* chronic obstructive pulmonary disease,
* liver disease,
* patients with kidney disease and joint or muscle disease will not be included
30 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Selcuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emine Cihan
Assist.Prof.Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Selcuk University
Konya, Selcuklu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024/09.17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.